Quantcast
Channel: All News Releases
Viewing all articles
Browse latest Browse all 5282

2026 MASH-TAG Oral Presentation: HepQuant DuO® Reveals Functional and Physiological Heterogeneity to Support Enhanced Clinical Trial Design

$
0
0

HepQuant, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, presented oral and poster data findings at the 2026-MASH-TAG conference January 8-10, 2026, Park City, UT. The presentation by Dr. Gregory T. Everson titled "Understanding the...


Viewing all articles
Browse latest Browse all 5282

Trending Articles